Transcriptional correlates of malaria in RTS,S/AS01-vaccinated African children: a matched case-control study

Seven year efficacy of RTS,S/AS01 malaria vaccine in young African children

Background

The RTS,S/AS01 malaria vaccine candidate is being evaluated for implementati

First results of phase 3 trial of RTS,S/AS01 malaria vaccine in African children.

BACKGROUND: An ongoing phase 3 study of the efficacy, safety, and immunogenicity of candidate malari

A phase 3 trial of RTS,S/AS01 malaria vaccine in African infants.

BACKGROUND: The candidate malaria vaccine RTS,S/AS01 reduced episodes of both clinical and severe ma

Acceptance, availability, and feasibility of RTS, S/AS01 malaria vaccine: A review

Abstract Introduction In malaria‐stricken regions, malaria continues to be one of the primary cau

Estimated impact of RTS,S/AS01 malaria vaccine allocation strategies in sub-Saharan Africa: A modelling study

Background The RTS,S/AS01 vaccine against Plasmodium falciparum malaria infection completed phas

RTS,S/AS01 mRNA Booster Platforms for Sustaining Protective Immunity Against Plasmodium Falciparum in African Children

Malaria caused by Plasmodium falciparum remained a leading cause of morbidity and mortality among Af